Authors:
Francesca Battaglin, Yasmine Baca, Pavel Brodskiy, Joanne Xiu, Priya Jayachandran, Sandra Algaze, Hiroyuki Arai, Shivani Soni, Evanthia T. Roussos Torres, Shannon M. Mumenthaler, Wu Zhang, Richard M. Goldberg, Benjamin Adam Weinberg, Emil Lou, Anthony Frank Shields, John Marshall, Wolfgang Michael Korn, Steve A. Kay, Heinz-Josef Lenz
Key Finding:
In colorectal cancer, the clock gene expression score is higher in primary versus metastatic samples, and clock gene expression is strongly associated with distinct molecular features, immune cell infiltration, angiogenesis pathway enrichment, and patient outcomes. A more nuanced re-classification of conventional gain-of-function mutant TP53 is warranted.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |